Suppr超能文献

[日本肺移植的适应证及其候选者的选择]

[Indications for lung transplantation and its selection of the candidates in Japan].

作者信息

Onuki T, Nitta S

机构信息

Tokyo Women's Medical University.

出版信息

Nihon Rinsho. 1999 Sep;57(9):2090-4.

Abstract

Although the annual number of lung transplant operation performed in the United States and Europe is over 1000, five year survival rate is under 50%, mainly because of obstructive bronchiolitis that is considered chronic rejection. Lung transplantation may be difficult to justify on the ground of survival consideration alone for the certain disease, such as emphysema and pulmonary hypertension. But functional recovery after lung transplantation especially, bilateral is reported very good. Among the diseases of indication of lung transplant, Cystic Fibrosis and alpha antitrypsin deficiency are very rare disease in Japan and emphysema that is most frequently reported indication in the United States, is also rare disease in the age group of lung transplantation candidate. So, idiopathic interstitial pneumonitis, pulmonary vascular disease and other miscellaneous disease are most possible indications for lung transplantation in Japan. These disease have different prognosis, we discussed the timing of registration and operation of lung transplantation in each disease.

摘要

尽管在美国和欧洲每年进行的肺移植手术超过1000例,但五年生存率低于50%,主要原因是被认为是慢性排斥反应的阻塞性细支气管炎。仅从生存考虑的角度来看,对于某些疾病,如肺气肿和肺动脉高压,肺移植可能很难说得通。但据报道,肺移植后的功能恢复,尤其是双侧肺移植后的功能恢复非常好。在肺移植的适应症疾病中,囊性纤维化和α-抗胰蛋白酶缺乏症在日本是非常罕见的疾病,而在美国最常报道的适应症肺气肿,在肺移植候选年龄组中也是罕见疾病。因此,特发性间质性肺炎、肺血管疾病和其他杂类疾病是日本肺移植最有可能的适应症。这些疾病预后不同,我们讨论了每种疾病肺移植登记和手术的时机。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验